Concepedia

Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)

Katsumasa Kuroi, Kojiro Shimozuma, Yasuo Ohashi, K Hisamatsu, Norikazu Masuda, Ayano Takeuchi, Toshihiko Aranishi, Satoshi Morita, Shozo Ohsumi, Frederick H. Hausheer

Supportive Care in Cancer · 2008 · 52 citations · 23 references

DOI

Concepts

References

23

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

Joseph A. Sparano, Molin Wang, Silvana Martino et al. · New England Journal of Medicine · 2008 · 1K citations · Full text

Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.

Nicholas J. Vogelzang, William Breitbart, David Cella et al. · PubMed · 1997 · 771 citations

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study

Ethan Basch, Alexia Iasonos, Tiffani L. McDonough et al. · The Lancet Oncology · 2006 · 646 citations

, , +9

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840

Andrew D. Seidman, Donald A. Berry, Constance Cirrincione et al. · Journal of Clinical Oncology · 2008 · 600 citations · Full text

How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30

Erik K. Fromme, Kristine M. Eilers, Motomi Mori et al. · Journal of Clinical Oncology · 2004 · 553 citations